Tag Archives: PBS

Guild welcomes ALP health reform

The Federal ALP’s commitment to establish a permanent Australian Health Reform Commission if they gain power at the forthcoming election has been welcomed by The Pharmacy Guild of Australia. Shadow Health Minister Catherine King says the proposed Commission would be an independent, legislated body charged with developing and overseeing a …

Read More »

MA’s ‘healthier future’ push

Keep the PBS strong and encourage continued investment in Australia’s health are two key messages in the federal budget submission from Medicines Australia (MA). In the submission, titled ‘Our choice for a healthier future’, MA also seeks a commitment to ensure the full implementation of, and commitment to the strategic …

Read More »

PBS lists new diabetes drug

A new treatment option is available for adult patients with Type 2 Diabetes. Steglatro (ertugliflozin), listed on the Pharmaceutical Benefits Scheme, is a new, SGLT2 inhibitor treatment option for Type 2 Diabetes Mellitus (T2DM). Steglatro provides healthcare care professionals with another option for patients that are currently on metformin +/- …

Read More »

NPSA on PBS drugs’ supply

The National Pharmaceutical Services Association (NPSA) has today welcomed the new operational guidelines for the Community Service Obligation (CSO) funding pool that underpins government policy for the distribution of PBS medicines. The updated CSO deeds, which are unique agreements between individual wholesalers and the Department of Health, outline how strict …

Read More »

Guild Dinner: Pharmacy gets bipartisan support

The importance of community pharmacy in Australia was strengthened as Pharmacy Guild of Australia President George Tambassis highlighted recent successes, outlined strategic initiatives and thanked Government leaders for their continued support for community pharmacy. “This is our opportunity to acknowledge the tremendous working relationships we have with all sides of …

Read More »

Simponi listing for non-radiographic axial spondyloarthritis

The federal government has opened a new front in the treatment of inflammatory arthritis, making the first ever medicine available on the PBS for people with a hidden form of arthritis where their immune system attacks the spine. Medical experts, patient groups and the Janssen Pharmaceutical Companies of Johnson & …

Read More »